vs
Side-by-side financial comparison of BITMINE IMMERSION TECHNOLOGIES, INC. (BMNR) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $11.0M, roughly 1.7× BITMINE IMMERSION TECHNOLOGIES, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -34583.9%, a 34580.9% gap on every dollar of revenue. On growth, BITMINE IMMERSION TECHNOLOGIES, INC. posted the faster year-over-year revenue change (627.6% vs -25.6%). Over the past eight quarters, BITMINE IMMERSION TECHNOLOGIES, INC.'s revenue compounded faster (251.9% CAGR vs -10.1%).
Bitmine Immersion Technologies is a tech firm focused on developing and providing professional immersion cooling solutions for high-performance computing scenarios, including cryptocurrency mining rig clusters and data center infrastructure. Its products boost hardware operating efficiency, cut energy consumption for heat control, extend high-power computing equipment lifespan, and help clients reduce long-term operational costs.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
BMNR vs RMTI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.0M | $18.3M |
| Net Profit | $-3.8B | $-554.0K |
| Gross Margin | 87.1% | 21.1% |
| Operating Margin | -34784.7% | -2.2% |
| Net Margin | -34583.9% | -3.0% |
| Revenue YoY | 627.6% | -25.6% |
| Net Profit YoY | -330212.5% | 26.7% |
| EPS (diluted) | $-8.40 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $11.0M | — | ||
| Q4 25 | $2.3M | $18.3M | ||
| Q3 25 | — | $15.9M | ||
| Q2 25 | $2.1M | $16.1M | ||
| Q1 25 | $1.5M | $18.9M | ||
| Q4 24 | $1.2M | $24.7M | ||
| Q3 24 | $682.4K | $28.3M | ||
| Q2 24 | $1.2M | $25.8M |
| Q1 26 | $-3.8B | — | ||
| Q4 25 | $-5.2B | $-554.0K | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | $-622.8K | $-1.5M | ||
| Q1 25 | $-1.2M | $-1.5M | ||
| Q4 24 | $-974.0K | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | $-654.2K | $343.0K |
| Q1 26 | 87.1% | — | ||
| Q4 25 | 55.3% | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | 23.9% | 15.6% | ||
| Q1 25 | 20.1% | 16.1% | ||
| Q4 24 | 10.0% | 14.7% | ||
| Q3 24 | 16.4% | 22.0% | ||
| Q2 24 | 18.1% | 17.6% |
| Q1 26 | -34784.7% | — | ||
| Q4 25 | -238564.8% | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | -22.8% | -8.4% | ||
| Q1 25 | -60.2% | -7.2% | ||
| Q4 24 | -73.6% | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | -43.6% | 2.0% |
| Q1 26 | -34583.9% | — | ||
| Q4 25 | -226955.7% | -3.0% | ||
| Q3 25 | — | -11.0% | ||
| Q2 25 | -30.4% | -9.3% | ||
| Q1 25 | -76.2% | -8.0% | ||
| Q4 24 | -81.1% | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | -53.4% | 1.3% |
| Q1 26 | $-8.40 | — | ||
| Q4 25 | $-15.98 | $-0.01 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | $-0.31 | $-0.05 | ||
| Q1 25 | $-0.58 | $-0.04 | ||
| Q4 24 | $-1.66 | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | $-0.26 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $879.6M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.9B | $37.0M |
| Total Assets | $9.9B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $879.6M | — | ||
| Q4 25 | $887.7M | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | $1.5M | $12.5M | ||
| Q1 25 | $483.0K | $11.4M | ||
| Q4 24 | $797.3K | $15.7M | ||
| Q3 24 | $499.0K | $12.3M | ||
| Q2 24 | — | $11.9M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $11.3B | $37.0M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | $2.9M | $30.4M | ||
| Q1 25 | $2.9M | $31.5M | ||
| Q4 24 | $3.8M | $32.6M | ||
| Q3 24 | $4.1M | $29.1M | ||
| Q2 24 | $4.6M | $23.5M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $11.5B | $57.1M | ||
| Q3 25 | — | $57.5M | ||
| Q2 25 | $8.3M | $52.6M | ||
| Q1 25 | $7.5M | $54.0M | ||
| Q4 24 | $7.9M | $59.2M | ||
| Q3 24 | $7.3M | $57.1M | ||
| Q2 24 | $8.2M | $53.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-88.2M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-88.2M | — | ||
| Q4 25 | $-228.4M | $2.3M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | $1.7M | $1.8M | ||
| Q1 25 | $-215.0K | $-3.5M | ||
| Q4 24 | $-96.0K | $865.0K | ||
| Q3 24 | $-30.0K | $4.3M | ||
| Q2 24 | $-42.7K | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-228.7M | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $-114.0K | $470.0K | ||
| Q3 24 | $-106.0K | $4.1M | ||
| Q2 24 | $-61.3K | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | -9975.2% | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | -9.5% | 1.9% | ||
| Q3 24 | -15.5% | 14.4% | ||
| Q2 24 | -5.0% | 4.5% |
| Q1 26 | 0.0% | — | ||
| Q4 25 | 16.4% | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 1.5% | 1.6% | ||
| Q3 24 | 11.1% | 0.7% | ||
| Q2 24 | 1.5% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BMNR
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
